Escitalopram Oxalate 5 mg Tablet, Film Coated, 180,000-count — NDC 0456-2006-00 (Billing 00456-2006-00)
This is a package of 180,000 tablets of Escitalopram Oxalate 5 mg Tablet, Film Coated from Allergan, Inc., first listed with the FDA Aug 2002 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 0456-2006-00 alone.
- Record
- FDA NDC Directory package listing · Drug for further processing
- Code segments
- 0456 labeler · 2006 product · 00 package
- Package marketed since
- Aug 14, 2002
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 0456200600 6
- FDA record last changed
- Aug 20, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 20, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
- It treats major depressive disorder and generalized anxiety disorder. Age limits depend on the product, so check with me or your prescriber about yours.
- Take it once a day, morning or evening, with or without food. Capsules should be swallowed whole. Follow your prescriber's directions.
- Please don't stop suddenly. Stopping can cause withdrawal-type symptoms. Talk to your prescriber about lowering the dose gradually.
- The most common are nausea, trouble sleeping, sleepiness, tiredness, sweating and sexual side effects such as delayed ejaculation or lower sex drive. Tell us if sexual problems bot...
Patient education
Drug interactions
Supplement & herbal interactions
Escitalopram may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 20, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 00456-2006-00 You're viewing this Main listing | 1 BAG in 1 DRUM / 180000 TABLET, FILM COATED in 1 BAG | — | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| escitalopram oxalate 5 mg 82009-0035-10 | Quallent | 1000 tablets | $0.043 | AB | Availability likely | — |
| Escitalopram 5 mg 65862-0373-01 | Aurobindo | 100 tablets | $0.043 | AB | Availability likely | — |
| Escitalopram Oxalate 5 mg 72603-0149-01 | NorthStar | 1000 tablets | $0.043 | AB | Availability likely | — |
| Escitalopram Oxalate 5 mg 33342-0036-11 | Macleods | 100 tablets | $0.046 | AB | FDA listed | — |
| Escitalopram 5 mg 59746-0279-01 | Jubilant | 100 tablets | $0.046 | AB | FDA listed | — |
| escitalopram oxalate 5 mg 71205-0313-30 | Proficient | 30 tablets | — | AB | FDA listed | — |
| Escitalopram Oxalate 5 mgthis 00456-2006-00 | Allergan, | 180000 tablets | — | — | FDA listed | — |
| Escitalopram Oxalate 5 mg 53746-0019-05 | Amneal | 500 tablets | — | AB | FDA listed | — |
| Escitalopram Oxalate 5 mg 65162-0019-03 | Amneal | 30 tablets | — | AB | FDA listed | — |
| Escitalopram 5 mg 71335-9687-01 | Bryant | 30 tablets | — | AB | FDA listed | — |
| Escitalopram 5 mg 00615-8475-05 | NCS | 15 tablets | — | AB | FDA listed | — |
| Escitalopram 5 mg 76420-0721-01 | Asclemed | 100 tablets | — | AB | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Escitalopram inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 20, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Allergan, Inc. labeler code 00456
- milnacipran hydrochloride 12.5 mg Tablet, Film Coated NDC 0456-1513-00
- Savella milnacipran hydrochloride 25 mg Tablet, Film Coated NDC 0456-1525-60
- milnacipran hydrochloride 25 mg Tablet, Film Coated NDC 0456-1526-00
- Savella milnacipran hydrochloride 50 mg Tablet, Film Coated NDC 0456-1550-60
- milnacipran hydrochloride 50 mg Tablet, Film Coated NDC 0456-1551-00
- Lexapro ESCITALOPRAM 5 mg Tablet, Film Coated NDC 0456-2005-01
- Lexapro ESCITALOPRAM 10 mg Tablet, Film Coated NDC 0456-2010-01
- Escitalopram Oxalate 10 mg Tablet, Film Coated NDC 0456-2011-00
- Lexapro ESCITALOPRAM 20 mg Tablet, Film Coated NDC 0456-2020-01
- Escitalopram Oxalate 20 mg Tablet, Film Coated NDC 0456-2021-00
- Fetzima LEVOMILNACIPRAN HYDROCHLORIDE Kit NDC 0456-2200-07
- Fetzima LEVOMILNACIPRAN HYDROCHLORIDE Kit NDC 0456-2202-28
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Medicare Part D spend CMS · PART D · 2026 (Q1)
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What "drug for further processing" means
FDA lists this package under the "drug for further processing" marketing category: Allergan, Inc. supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |